Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pamela S. Shaw"'
Publikováno v:
Cancer Research. 82:1756-1756
Introduction: XMT-1660 is a first-in-class Dolasynthen Antibody-Drug Conjugate (ADC) targeting B7-H4 and carrying a DolaLock payload with controlled bystander effect. B7-H4 is an immunoregulatory protein that is expressed in breast, ovarian and endom
Autor:
Agoston T. Agoston, Rick Nicoletti, Abigail E. Witt, Pamela S. Shaw, Helen L. Yang, Naghmeh Salimi, Elin S. Agoston
Publikováno v:
Cancer Research. 77:821-821
Although relevant, the genomic and proteomic alterations between original tumor tissue and newly established cell lines are frequently uncharacterized. In developing a novel cell model (Powder) of high grade serous carcinoma (HGSC), we followed the s